JPH11510505A5 - - Google Patents
Info
- Publication number
- JPH11510505A5 JPH11510505A5 JP1997508246A JP50824697A JPH11510505A5 JP H11510505 A5 JPH11510505 A5 JP H11510505A5 JP 1997508246 A JP1997508246 A JP 1997508246A JP 50824697 A JP50824697 A JP 50824697A JP H11510505 A5 JPH11510505 A5 JP H11510505A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9516287.1 | 1995-08-09 | ||
| GB9516287A GB2304047A (en) | 1995-08-09 | 1995-08-09 | Pharmaceutical compositions containing cytokines |
| PCT/GB1996/001930 WO1997005894A1 (en) | 1995-08-09 | 1996-08-08 | Pharmaceutical composition containing il-10 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JPH11510505A JPH11510505A (ja) | 1999-09-14 |
| JPH11510505A5 true JPH11510505A5 (enExample) | 2004-09-09 |
| JP4050317B2 JP4050317B2 (ja) | 2008-02-20 |
Family
ID=10778967
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP50824697A Expired - Fee Related JP4050317B2 (ja) | 1995-08-09 | 1996-08-08 | Ｉｌ−１０含有医薬組成物 |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US6387364B1 (enExample) |
| EP (1) | EP0871473B1 (enExample) |
| JP (1) | JP4050317B2 (enExample) |
| AT (1) | ATE229814T1 (enExample) |
| AU (1) | AU719089B2 (enExample) |
| CA (1) | CA2229078C (enExample) |
| DE (1) | DE69625516T2 (enExample) |
| DK (1) | DK0871473T3 (enExample) |
| ES (1) | ES2187665T3 (enExample) |
| GB (1) | GB2304047A (enExample) |
| PT (1) | PT871473E (enExample) |
| WO (1) | WO1997005894A1 (enExample) |
| ZA (1) | ZA966744B (enExample) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0941108B1 (en) * | 1996-12-04 | 2002-10-16 | Renovo Limited | Wound healing and treatment of fibrosis |
| WO1998033516A1 (en) * | 1997-02-05 | 1998-08-06 | Schering Corporation | Use of il-4 and/or il-10 to treat proliferative glomerulonephritis |
| CA2384076A1 (en) * | 1999-09-08 | 2001-03-15 | Schering Corporation | Novel uses of mammalian ccr6 receptors and related reagents |
| US20060258562A1 (en) * | 2000-07-31 | 2006-11-16 | Healor Ltd. | Methods and pharmaceutical compositions for healing wounds |
| ATE516820T1 (de) | 2000-09-29 | 2011-08-15 | Schering Corp | Pegyliertes interleukin 10 |
| US20030148952A1 (en) * | 2001-10-18 | 2003-08-07 | Crombleholme Timothy M. | Methods and materials for the recruitment of endothelial cells |
| NZ573737A (en) * | 2003-07-15 | 2011-06-30 | Univ Bar Ilan | Methods and pharmaceutical compositions for healing wounds comprising a PKC modulator |
| DK1651161T3 (da) | 2003-08-07 | 2012-01-30 | Healor Ltd | Farmaceutiske præparater og fremgangsmåder til at fremme sårheling |
| GB0500643D0 (en) * | 2005-01-13 | 2005-02-23 | Renovo Ltd | Medicaments |
| GB0524103D0 (en) | 2005-11-26 | 2006-01-04 | Medical Res Council | Healing |
| NZ597098A (en) | 2006-09-28 | 2013-05-31 | Merck Sharp & Dohme | Use of pegylated il-10 to treat cancer |
| JP5960944B2 (ja) | 2006-11-15 | 2016-08-02 | コーダ セラピューティクス， インコーポレイテッド | 創傷治癒のための改善された方法および組成物 |
| CN101835486B (zh) * | 2007-07-30 | 2012-12-12 | 希尔洛有限公司 | 用于治疗创伤的药物组合物以及相关方法 |
| GB0724231D0 (en) * | 2007-12-12 | 2008-01-30 | Renono Ltd | Methods for inhibiting scarring |
| EP2234656A2 (en) | 2007-12-21 | 2010-10-06 | Coda Therapeutics, Inc. | Improved medical devices |
| JP2011507862A (ja) * | 2007-12-21 | 2011-03-10 | コーダ セラピューティクス， インコーポレイテッド | 異常瘢痕または過剰瘢痕の治療のための抗コネキシン４３ポリヌクレオチドの使用 |
| JP2011507856A (ja) * | 2007-12-21 | 2011-03-10 | コーダ セラピューティクス， インコーポレイテッド | 整形外科状態の治療のための抗コネキシンポリヌクレオチド、ペプチド、または抗体の使用 |
| WO2009120799A2 (en) * | 2008-03-25 | 2009-10-01 | Paloma Pharmaceuticals, Inc. | Methods of treating fibrotic disorders |
| EP3348281B1 (en) | 2008-12-17 | 2023-07-05 | Merck Sharp & Dohme Corp. | Mono- and di-peg il-10 production; and uses |
| CN102325789A (zh) * | 2009-02-24 | 2012-01-18 | 希尔洛有限公司 | 用于治疗痤疮和其它病症的内脂素治疗药物 |
| US9381187B2 (en) | 2011-02-16 | 2016-07-05 | Paloma Pharmaceuticals, Inc. | Radiation countermeasure agents |
| EP2691515A2 (en) * | 2011-03-31 | 2014-02-05 | President and Fellows of Harvard College | A unique population of regulatory t cells that regulate tissue regeneration and wound healing |
| AU2013263502B2 (en) * | 2012-05-18 | 2018-02-08 | Otago Innovation Limited | Combination treatments and compositions for wound healing |
| CN105209054A (zh) | 2013-04-18 | 2015-12-30 | 阿尔莫生物科技股份有限公司 | 使用白细胞介素-10治疗疾病和病症的方法 |
| JP2016528879A (ja) | 2013-06-17 | 2016-09-23 | アルモ・バイオサイエンシーズ・インコーポレイテッド | タンパク質の同一性および安定性を評価する方法 |
| US10098929B2 (en) | 2013-08-02 | 2018-10-16 | Children's Hospital Medical Center | Method of reducing scar formation in healing of dermal wounds by administering interleukin-10 and hyaluronan |
| HK1226308A1 (zh) | 2013-08-30 | 2017-09-29 | Armo Biosciences, Inc. | 使用白细胞介素-10治疗疾病和病症的方法 |
| US11413332B2 (en) | 2013-11-11 | 2022-08-16 | Armo Biosciences, Inc. | Methods of using interleukin-10 for treating diseases and disorders |
| US10293043B2 (en) | 2014-06-02 | 2019-05-21 | Armo Biosciences, Inc. | Methods of lowering serum cholesterol |
| JP6683686B2 (ja) | 2014-08-22 | 2020-04-22 | オークランド ユニサービシーズ リミティド | チャネル調節剤 |
| KR20170068553A (ko) | 2014-10-14 | 2017-06-19 | 아르모 바이오사이언시스 인코포레이티드 | 인터류킨-15 조성물 및 이의 용도 |
| JP6675394B2 (ja) | 2014-10-22 | 2020-04-01 | アルモ・バイオサイエンシーズ・インコーポレイテッド | 疾患及び障害の治療のためにインターロイキン−１０を使用する方法 |
| US10618970B2 (en) | 2015-02-03 | 2020-04-14 | Armo Biosciences, Inc. | Method of treating cancer with IL-10 and antibodies that induce ADCC |
| US20160361415A1 (en) | 2015-05-28 | 2016-12-15 | Armo Biosciences, Inc. | Methods of Using Interleukin-10 for Treating Diseases and Disorders |
| JP7053453B2 (ja) | 2015-08-25 | 2022-04-12 | アルモ・バイオサイエンシーズ・インコーポレイテッド | 疾患及び障害を治療するためのインターロイキン１０の使用方法 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4929442A (en) | 1986-09-26 | 1990-05-29 | Exovir, Inc. | Compositions suitable for human topical application including a growth factor and/or related materials |
| DE3889479T2 (de) | 1987-02-27 | 1994-12-22 | Eastman Kodak Co | Mit Nieder-pI-Protein beschichtete Membranstruktur und Verfahren zu ihrer Herstellung und Verwendung. |
| JPH0611706B2 (ja) * | 1989-01-20 | 1994-02-16 | ザ ユニバーシティ オブ メルボルン | フィブリン溶解 |
| US5242902A (en) * | 1989-09-06 | 1993-09-07 | The Regents Of The University Of California | Defensin peptide compositions and methods for their use |
| EP0502080A4 (en) * | 1989-11-21 | 1993-02-10 | The University Of Melbourne | Anti-inflammatory compositions and methods |
| DK0526544T3 (da) | 1990-04-11 | 1999-06-21 | Brigham & Womens Hospital | Terapeutiske anvendelser af actinbindende forbindelser |
| JPH0747545B2 (ja) * | 1991-01-10 | 1995-05-24 | シェリング・コーポレーション | 創傷治癒及び修復の修復段階を促進し、かつ感染した創傷及び糖尿病哺乳類の創傷の治癒を促進するためのｉｌ−４の用途 |
| GB9106678D0 (en) * | 1991-03-28 | 1991-05-15 | Ferguson Mark W J | Wound healing |
| AU8647991A (en) | 1991-08-26 | 1993-03-16 | State of Oregon Acting by and Through The State of Board of Higher Education on Behalf of The Oregon Health Sciences University, The | Keratinocyte-derived conditioned medium as a source of growth factors |
| GB9206861D0 (en) * | 1992-03-28 | 1992-05-13 | Univ Manchester | Wound healing and treatment of fibrotic disorders |
| GB9207732D0 (en) * | 1992-04-06 | 1992-05-27 | Isis Innovation | Wound repair |
| WO1994027640A1 (en) * | 1993-05-27 | 1994-12-08 | The Regents Of The University Of Michigan | Method of treatment and prevention of immune complex-induced lung injury |
| IL110413A0 (en) | 1993-07-26 | 1994-10-21 | Schering Corp | Agonists and antagonists of human interleukin-10 |
| JP4083794B2 (ja) * | 1994-03-29 | 2008-04-30 | レノボ・リミテッド | 創傷の治癒 |
| EP1621206A1 (en) * | 1994-12-12 | 2006-02-01 | Beth Israel Deaconess Medical Center, Inc. | Chimeric cytokines and uses thereof |
| GB9516012D0 (en) * | 1995-08-04 | 1995-10-04 | Univ Manchester | Pharmaceutical composition |
| GB2304045A (en) * | 1995-08-04 | 1997-03-12 | Univ Manchester | Betaglycan compositions for promoting the healing of wounds and fibrotic diseases |
-
1995
- 1995-08-09 GB GB9516287A patent/GB2304047A/en not_active Withdrawn
-
1996
- 1996-08-08 EP EP96926507A patent/EP0871473B1/en not_active Expired - Lifetime
- 1996-08-08 WO PCT/GB1996/001930 patent/WO1997005894A1/en not_active Ceased
- 1996-08-08 AU AU66660/96A patent/AU719089B2/en not_active Ceased
- 1996-08-08 PT PT96926507T patent/PT871473E/pt unknown
- 1996-08-08 ES ES96926507T patent/ES2187665T3/es not_active Expired - Lifetime
- 1996-08-08 CA CA2229078A patent/CA2229078C/en not_active Expired - Fee Related
- 1996-08-08 DK DK96926507T patent/DK0871473T3/da active
- 1996-08-08 ZA ZA9606744A patent/ZA966744B/xx unknown
- 1996-08-08 US US09/011,027 patent/US6387364B1/en not_active Expired - Lifetime
- 1996-08-08 AT AT96926507T patent/ATE229814T1/de active
- 1996-08-08 DE DE69625516T patent/DE69625516T2/de not_active Expired - Lifetime
- 1996-08-08 JP JP50824697A patent/JP4050317B2/ja not_active Expired - Fee Related
-
2002
- 2002-02-26 US US10/082,221 patent/US7052684B2/en not_active Expired - Fee Related